KalVista Pharmaceuticals
KALV
KALV
88 hedge funds and large institutions have $265M invested in KalVista Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 23 increasing their positions, 29 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
15% less first-time investments, than exits
New positions opened: 17 | Existing positions closed: 20
21% less repeat investments, than reductions
Existing positions increased: 23 | Existing positions reduced: 29
Holders
88
Holding in Top 10
4
Calls
$6K
Puts
–
Top Buyers
| 1 | +$13M | |
| 2 | +$7.16M | |
| 3 | +$5.69M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$4.28M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.38M |
Top Sellers
| 1 | -$9.75M | |
| 2 | -$5.05M | |
| 3 | -$4.95M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$4.28M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$4.01M |